Gene fusion of molecular adjuvant C3d to hCGβ enhances the anti-hCGβ antibody response in DNA immunization

Journal of Reproductive Immunology

Volumn 60, Issue 2, 2003, Pages 129-141

  Li, Da Jin ^a   Wang, Hong Mei ^a   Li, Lei ^a   Zhao, Xin Rong ^a   Wang, Ming Yan ^a   Zhu, Ying ^a   Meng, Yi ^a   Yuan, Min Min ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

C3d molecular adjuvant; DNA immunization; Eukaryotic cell; Expression in vitro; hCG

Indexed keywords

ADJUVANT; ANTIBIOTIC G 418; ANTIBODY; CHORIONIC GONADOTROPIN BETA SUBUNIT; CHORIONIC GONADOTROPIN BETA SUBUNIT ANTIBODY; COMPLEMENT COMPONENT C3D; COMPLEMENTARY DNA; CONTRACEPTIVE VACCINE; DNA; HYBRID PROTEIN; IMMUNOGLOBULIN G ANTIBODY; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CALCULATION; CELL SECRETION; CELL STRAIN COS7; CHIMERA; CHO CELL; CONTROLLED STUDY; CYTOMEGALOVIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; EUKARYOTE; EVALUATION; FEMALE; GENE; GENE FUSION; GENETIC TRANSFECTION; IMMUNIZATION; IMMUNOAFFINITY CHROMATOGRAPHY; IMMUNOGENICITY; IMMUNOHISTOCHEMISTRY; INOCULATION; MOLECULAR CLONING; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PURIFICATION; RADIOIMMUNOASSAY; RAJI CELL; SCREENING; SUPERNATANT; TIME; VACCINATION; WESTERN BLOTTING;

EID: 0344861949     PISSN: 01650378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jri.2003.09.001     Document Type: Article

References (19)

1. Carroll M.C. The role of complement in B cell activation and tolerance. Adv. Immunol. 74:2000;61-88.
2. Chakravarty L., Zabel M.D., Weis J.J., Weis J.H. Depletion of lyn kinase from the BCR complex and inhibition of B cell activation by excess CD21 ligation. Int. Immunol. 14:2002;139-146.
3. Cherukuri A., Cheng P.C., Pierce S.K. The role of the CD19/CD20 complex in B cell processing and presentation of complement-tagged antigens. J. Immunol. 167:2001;163-172.
4. Dempsey P.W., Allison M.E.D., Akkaraju S., Goodnow C.C., Fearon D.T. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science. 271:1996;348-350.
5. Fakher M., Wu J., Qin D., Szakal A., Tew J. Follicular dendritic cell accessory activity crosses MHC and species barriers. Eur. J. Immunol. 31:2001;176-185.
6. Green T.D., Newton B.R., Rota P.A., Xu Y., Robinson H.L., Ross T.M. C3d enhancement of neutralizing antibodies to measles hemagglutinin. Vaccine. 20:2001;242-248.
7. Gupta A., Pal R., Ahlawat S., Bhatia P., Singh O. Enhanced immunogenicity of a contraceptive vaccine using diverse synthetic carriers with permissible adjuvant. Vaccine. 19:2001;3383-3389.
8. Lou D., Kohler H. Enhanced molecular mimicry of CEA using photoaffinity crosslinked C3d peptide. Nat. Biotechnol. 16:1998;458-462.
9. Mandokhot A., Pal R., Nagpal S., Chauhan V.S., Ahlawat S., Singh O. Humoral hyporesponsiveness to a conjugate contraceptive vaccine and its bypass by diverse carriers using permissible adjuvant. Clin. Exp. Immunol. 122:2000;101-108.
10. O'Rand M.G., Lea I.A. Designing an effective immunocontraceptive. J. Reprod. Immunol. 36:1997;51-59.
11. Porakishvili N., Chiesa M.D., Chikadze N., Martensen P., Justesen J., Lund T., Delves P.J., Roitt I.M. Elimination of luteinizing hormone cross-reactive epitopes from human chorionic gonadotropin. Vaccine. 20:2002;2053-2059.
12. Renjifo X., Wolf S., Pastoret P.P. Carrier-induced, hapten specific suppression: a problem of antigen presentation? J. Immunol. 161:1998;702-706.
13. Ross T.M., Xu Y., Bright R.A., Robinson H.L. C3d enhancement of antibodies to hemagglutinin accelerates protection against influenza virus challenge. Nat. Immunol. 2:2000;127-131.
14. Schutze M.P., Deriaud E., Przewlocki G., Lecrec C. Carrier-induced epitopic suppression is initiated through clonal dominance. J. Immunol. 142:1989;2635-2640.
15. Singh O., Rao L.V., Gaur A., Sharma N.C., Alam A., Talwar G.P. Antibody response and characteristics of antibodies in women immunized with three contraceptive vaccines inducing antibodies against human chorionic gonadotropin. Fertil. Steril. 52:1989;739-744.
16. Singh M., Das S.K., Suri S., Singh O., Talwar G.P. Regain of fertility and normality of progeny born during below protective threshold antibody titers in women immunized with the HSD-hCG vaccine. Am. J. Reprod. Immunol. 39:1998;395-398.
17. Suradhat S., Braun R.P., Lewis P.J., Babiuk L.A., van Drunen Littel-van den Hurk S., Griebel P.J., Baca-Estrada M.E. Fusion of C3d molecule with bovine rotavirus VP7 or bovine herpesvirus type 1 glycoprotein D inhibits immune responses following DNA immunization. Vet. Immunol. Immunopathol. 83:2001;79-92.
18. Talwar G.P., Singh O.M., Gupta S.K., Hasnain S.E., Pal R., Majumbar S.S., Vreti S., Jukhopadhay A., Srinivasan J., Deshmukh U., Ganga S., Mandokhot A., Gupta A. The HSD-hCG vaccine prevents pregnancy in women: feasibility study of a reversible safe contraceptive vaccine. Am. J. Reprod. Immunol. 37:1997;153-160.
19. Test S.T., Mictsuyoshi J., Connolly C.C., Lucas A.H. Increased immunogenecity and induction of class switching by conjugation of complement C3d to pneumococcal serotype 14 capsular polysaccharide. Infect. Immun. 69:2001;3031-3043.